Position in AZN
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$2,687,672
-$221,320 QoQ
Shares Held
14,174
-3.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#477
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 6%
Shared 94%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Venturi Wealth Management, LLC holds $70,939,053 across 11 Drug Manufacturers - General names. AZN ranks #5 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
23,196 | $27,821,980 | |
| 2 | ABBV |
AbbVie Inc.
|
100,019 | $25,168,780 | |
| 3 | JNJ |
Johnson & Johnson
|
19,172 | $4,869,112 | |
| 4 | AMGN |
Amgen Inc
|
10,528 | $3,812,398 | |
| 5 | AZN |
Astrazeneca PLC
This page
|
14,174 | $2,687,672 | |
| 6 | NVS |
Novartis AG
|
17,084 | $2,677,404 | |
| 7 | MRK |
Merck & Co., Inc.
|
10,622 | $1,364,926 | |
| 8 | NVO |
Novo Nordisk A S
|
24,965 | $1,196,822 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,687,672 | 14,174 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $2,908,992 | 14,750 | Shares | Other | 2026-04-21 | |
| No filing history on record for this holder in this stock. | ||||||